Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Monday's Intraday Session

Author: Benzinga Insights | June 05, 2023 01:31pm

Gainers

  • INVO Bioscience (NASDAQ:INVO) stock rose 50.9% to $0.32 during Monday's regular session. Trading volume for this security as of 13:30 EST is 5.4 million, which is 2816.2% of its average full-day volume over the last 100 days. The company's market cap stands at $4.4 million.
  • Timber Pharmaceuticals (AMEX:TMBR) stock increased by 38.92% to $2.07. As of 13:30 EST, Timber Pharmaceuticals's stock is trading at a volume of 12.3 million, which is 18950.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $6.3 million.
  • Pasithea Therapeutics (NASDAQ:KTTA) shares moved upwards by 24.99% to $0.5. Trading volume for Pasithea Therapeutics's stock is 1.0 million as of 13:30 EST. This is 2408.9% of its average full-day volume over the last 100 days. The company's market cap stands at $13.0 million.
  • Regencell Bioscience (NASDAQ:RGC) shares increased by 22.22% to $27.5. The market value of their outstanding shares is at $357.8 million.
  • Replimune Group (NASDAQ:REPL) stock rose 20.85% to $22.95. Trading volume for this security as of 13:30 EST is 656.2K, which is 116.0% of its average full-day volume over the last 100 days. The company's market cap stands at $1.3 billion.
  • Scilex Holding (NASDAQ:SCLX) stock moved upwards by 20.74% to $7.74. The current volume of 321.0K shares is 48.9% of Scilex Holding's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $1.1 billion.

Losers

  • Bellerophon Therapeutics (NASDAQ:BLPH) stock declined by 85.4% to $1.03 during Monday's regular session. Trading volume for Bellerophon Therapeutics's stock is 9.4 million as of 13:30 EST. This is 775.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $10.7 million.
  • Castle Biosciences (NASDAQ:CSTL) stock fell 47.61% to $11.91. The current volume of 6.3 million shares is 3847.5% of Castle Biosciences's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $317.8 million.
  • Mallinckrodt (AMEX:MNK) stock fell 41.23% to $1.44. As of 13:30 EST, this security is trading at a volume of 643.9K shares, making up 45.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $18.9 million.
  • PDS Biotechnology (NASDAQ:PDSB) stock decreased by 26.53% to $6.92. Trading volume for PDS Biotechnology's stock is 6.7 million as of 13:30 EST. This is 1475.1% of its average full-day volume over the last 100 days. The company's market cap stands at $213.3 million.
  • HTG Molecular Diagnostics (NASDAQ:HTGM) stock declined by 20.86% to $1.68. As of 13:30 EST, this security is trading at a volume of 247.1K shares, making up 133.8% of its average full-day volume over the last 100 days. The company's market cap stands at $3.7 million.
  • Elevation Oncology (NASDAQ:ELEV) shares declined by 20.77% to $2.81. As of 13:30 EST, this security is trading at a volume of 2.8 million shares, making up 145.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $68.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BLPH CSTL ELEV HTGM INVO KTTA MNK PDSB REPL RGC SCLX TMBR

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist